SPOTLIGHT -
Envafolimab Combo Yields Efficacy and Safety in Liver Cancer Subtype
Envafolimab in combination with lenvatinib and transarterial chemoembolization demonstrated efficacy and safety among patients with unresectable hepatocellular carcinoma.
Phase 2 Cilta-Cel Efficacy Data Highlight Potential Fulfillment of Unmet Need in Early-Line R/R Multiple Myeloma
Updated findings from the phase 2 CARTITUDE-2 trial highlighted the promising efficacy of ciltacabtagene autoleucel in patients with relapsed or refractory multiple myeloma following early relapse.
Those With Acalabrutinib-Intolerant B-Cell Malignancies Appear to Benefit From Zanubrutinib
Patients with B-cell malignancies intolerant to acalabrutinib appeared to derive clinically meaningful benefit from zanubrutinib.
Early Efficacy Observed With Trastuzumab Deruxtecan±Pertuzumab for HER2+ Metastatic Breast Cancer
Patients with HER2-positive metastatic breast cancer experienced promising preliminary safety and efficacy with trastuzumab deruxtecan alone and in combination with pertuzumab.
